NCT04205071 2021-01-19
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Withdrawn
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute